RESEARCH EDUCATION CORE ABSTRACT: The CDU/UCLA Cancer Center Partnership's Research Education Core is central component to provide and facilitate research educational experiences for undergraduate, graduate, medical, post-doctoral, medical residents, clinical fellows, and early stage investigators (ESIs) to conduct translational cancer health disparities research. In addition, this Research Education Core will continue to play a critical role in providing research instruction to community partners in partnership with our community outreach core and health service providers that include: community oncologists, primary care physicians and internists engaged in our Clinical Resource Service Core. The Research Education Core will serve as portals to the other cores to enhance cancer education, care, treatment and prevention. The Research Education Core will provde interactive and integrated approaches for interdisciplinary and transdisciplinary programs and activities for reducing cancer health disparities. The Core will provide four unique research experience programs: 1) a short-term 8-12 week summer intensive research experience for undergraduate-level students in basic, clinical, or community-based science, 2) research internships for graduate and medical students and for post-doctoral and ESIs, 3) long- term research experiences for post-doctoral and ESIs, and 4) a community/academic research experience for community faculty. Student scholars will be placed either at CDU or UCLA with mentors who have experience in cancer health disparities and the student's research interest. The mentor will guide them on a hypothesis- driven project. In addition to hands-on experience, scholars are required to participate in both scientific and career-development seminars and workshops, research-in-progress presentations, professional presentations, manuscript development, and grant proposal development (for graduate to ESIs). The Core has developed an Internal Mentoring Committee composed of CDU and UCLA PIs and IAC members to review the individualized outcomes of scholars, particularly ESIs. Evaluation and Tracking outcomes will be regularly reported and discussed as part of the Planning and Evaluation Core activities. The overarching goal is to develop a diverse cadre of scholars, through hands-on research experiences, into tomorrow's leaders who address will the social, community-based, and biomedical challenges which contribute to cancer disparities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54CA143930-06
Application #
9041149
Study Section
Special Emphasis Panel (ZCA1-PCRB-C (O1))
Project Start
2009-09-29
Project End
2020-08-31
Budget Start
2015-09-25
Budget End
2016-08-31
Support Year
6
Fiscal Year
2015
Total Cost
$36,871
Indirect Cost
$21,516
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Boonyaratanakornkit, Viroj; Hamilton, Nalo; Márquez-Garbán, Diana C et al. (2018) Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer. Mol Cell Endocrinol 466:51-72
Elshimali, Yahya I; Wu, Yong; Khaddour, Hussein et al. (2018) Optimization Of Cancer Treatment Through Overcoming Drug Resistance. J Cancer Res Oncobiol 1:
Maxwell, Annette E; Crespi, Catherine M; Arce, Anthony A et al. (2017) Exploring the effects of longstanding academic-community partnerships on study outcomes: A case study. Prev Med Rep 8:101-107
Hamilton, Nalo; Austin, David; Márquez-Garbán, Diana et al. (2017) Receptors for Insulin-Like Growth Factor-2 and Androgens as Therapeutic Targets in Triple-Negative Breast Cancer. Int J Mol Sci 18:
Wu, Y; Vadgama, J V (2017) Androgen Receptor as a Potential Target for Treatment of Breast Cancer. Int J Cancer Res Mol Mech 3:
Wu, Yong; Yu, Xiaoting; Yi, Xianghua et al. (2017) Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis. Cancer Res 77:1383-1394
Bhat, Kruttika; Sarkissyan, Marianna; Wu, Yanyuan et al. (2017) GRO? overexpression drives cell migration and invasion in triple negative breast cancer cells. Oncol Rep 38:21-30
Wu, Yanyuan; Tran, Trinh; Dwabe, Sami et al. (2017) A83-01 inhibits TGF-?-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells. Breast Cancer Res Treat 163:449-460
Gelfand, Robert; Vernet, Dolores; Bruhn, Kevin W et al. (2017) Long-term exposure of MCF-7 breast cancer cells to ethanol stimulates oncogenic features. Int J Oncol 50:49-65
Dong, Yunzhou; Wu, Yong; Cui, Mei-Zhen et al. (2017) Lysophosphatidic Acid Triggers Apoptosis in HeLa Cells through the Upregulation of Tumor Necrosis Factor Receptor Superfamily Member 21. Mediators Inflamm 2017:2754756

Showing the most recent 10 out of 52 publications